Menu

Archive | .

Stereotactic Ablative Radiation for RCC: Novel Paradigms Emerge as the Myth of Radioresistance Fades

Raquibul Hannan, MD, PhD Associate Professor of Radiation Oncology UT Southwestern Medical Center Dallas, Texas     Are we at an inflection point for the use of radiotherapy in renal cell carcinoma? Perhaps. Definitive, high-dose-per-fraction stereotactic radiation is having a sharp impact as an option for a growing population of patients. A review of the […]

Continue Reading 0

Optimizing Sunitinib Dosing:
Balancing Efficacy and Tolerability

Pavlos Msaouel, MD, PhD Oncology Fellow, The University of Texas MD Anderson Cancer Center Houston, Texas     Nizar M. Tannir, MD Professor, Department of GenitourinaryMedical Oncology Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center and Deputy Department Chair Department of Genitourinary Medical Oncology Division of Cancer Medicine The University of Texas MD Anderson Cancer […]

Continue Reading 0